Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
AtriCure, Inc.

AtriCure, Inc. (ATRC) Stock Overview

Explore AtriCure, Inc.’s financial performance, market position, analyst ratings, and future outlook.

ATRC●NASDAQ
HealthcareMedical - Instruments & Supplies
$62.48
$1.06(1.73%)
U.S. Market opens in 16h 7m

AtriCure, Inc. (ATRC)

Meyka AI Score

Z

Key Financials

Market Cap3.2B
P/E Ratio288.28
EPS (TTM)$0.03
ROE0.02%
Fundamental Analysis

AI Price Forecasts

1 Month$50.59
3 Months$59.20
1 Year Target$42.62

ATRC Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of AtriCure, Inc. (NASDAQ: ATRC) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, AtriCure, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ATRC on the NASDAQ shows an RSI of 68.65, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $42.62 for the NASDAQ listing.

Key metrics behind AtriCure, Inc.'s NASDAQ-traded stock include a P/E ratio of 288.28 and a market capitalization of 3.2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ATRC on the NASDAQ.

Price Performance (NASDAQ: ATRC)

1-Day Change
1.73%
5-Day Change
6.006%
1-Month Change
7.63%
3-Month Change
52.80%
6-Month Change
128.53%
Year-to-Date (YTD) Change
57.94%
1-Year Change
76.30%
3-Year Change
86.40%
5-Year Change
-16.76%
All-Time (Max) Change
343.75%

Contact Information

https://www.atricure.com
513 755 4100
7555 Innovation Way, Mason, OH, 45040

Company Facts

13,500 Employees
IPO DateAug 5, 2005
CountryUS
Actively Trading

Frequently Asked Questions